Clinical Trials Directory

Trials / Terminated

TerminatedNCT01541813

Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.

Clinical, Biological, Genetic and Functional Characterization of Rare Iron Overload Phenotypes Associated With Hepcidin Deficiency Except C282Y Homozygosity.

Status
Terminated
Phase
Study type
Observational
Enrollment
62 (actual)
Sponsor
Rennes University Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Chronic iron overload is responsible for morbidity and mortality. There are many genetic and acquired causes. One of them is an hepcidin deficiency. Hepcidin is the regulating hormone for iron. The study explores this specific cause, and aim to characterize this iron overload in term of clinical, biological, genetic and functional specificities.

Detailed description

One of chronic iron overload profiles is a deficit in hepcidin. Hepcidin is the regulating hormone for iron. This specific profile is characterized by an elevated serum iron, an elevated transferrin saturation, and parenchymal damages of iron overload. This disease is not connected with known mutations of iron metabolism genes. The main objective of this study is the clinical, biological, genetic and functional characterization of rare iron overload phenotypes associated with hepcidin deficiency except C282Y homozygosity.

Conditions

Timeline

Start date
2011-03-01
Primary completion
2014-08-01
Completion
2014-12-01
First posted
2012-03-01
Last updated
2015-03-10

Locations

10 sites across 1 country: France

Source: ClinicalTrials.gov record NCT01541813. Inclusion in this directory is not an endorsement.

Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization. (NCT01541813) · Clinical Trials Directory